Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Antibiotic Selection for Sinusitis After Recent Augmentin Treatment

Introduction to Antibiotic Selection

  • The American Academy of Otolaryngology-Head and Neck Surgery recommends a respiratory fluoroquinolone (gatifloxacin, levofloxacin, or moxifloxacin) as the most appropriate antibiotic choice for a patient with impaired sinus drainage who was recently treated with Augmentin (amoxicillin/clavulanate) a few weeks ago 1

Rationale for Antibiotic Selection

  • Recent antibiotic exposure (within 4-6 weeks) is a significant risk factor for harboring resistant organisms, requiring a different class of antibiotics, according to the American Academy of Otolaryngology-Head and Neck Surgery 1, 2
  • Impaired sinus drainage suggests a more complicated case that may require broader coverage, as suggested by the Journal of Allergy and Clinical Immunology 3
  • The American Academy of Otolaryngology-Head and Neck Surgery recommends respiratory fluoroquinolone (gatifloxacin, levofloxacin, or moxifloxacin) as a first-line treatment option, providing excellent coverage for both S. pneumoniae and H. influenzae, including resistant strains 1, 2
  • High-dose amoxicillin-clavulanate (4g/250mg per day for adults) is an alternative option if the previous course was standard-dose and if more than 4 weeks have passed, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 1

Treatment Algorithm

  • The American Academy of Otolaryngology-Head and Neck Surgery suggests assessing severity and risk factors, and using a respiratory fluoroquinolone for mild disease with recent antibiotic use (Augmentin) 1
  • The duration of therapy should be 10-14 days, as recommended by the Journal of Allergy and Clinical Immunology 3

Important Considerations and Pitfalls

  • The Journal of Allergy and Clinical Immunology advises avoiding the use of the same antibiotic class that was recently used, as this increases the risk of treatment failure due to resistant organisms 3, 4
  • Respiratory fluoroquinolones should be reserved for patients with recent antibiotic use or moderate disease to prevent development of resistance, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 2

Special Populations

  • For children, the American Academy of Otolaryngology-Head and Neck Surgery recommends high-dose amoxicillin-clavulanate (90mg/6.4mg per kg per day) or cefdinir, cefpodoxime, or cefuroxime as alternative options if Augmentin was recently used 5, 6
  • For penicillin-allergic patients, the American Academy of Otolaryngology-Head and Neck Surgery recommends respiratory fluoroquinolones for adults, and clindamycin (if S. pneumoniae is confirmed) or consultation for desensitization for children with true Type I hypersensitivity 2

REFERENCES

1

antimicrobial treatment guidelines for acute bacterial rhinosinusitis. [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2004

2

antimicrobial treatment guidelines for acute bacterial rhinosinusitis. [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2004

5

antimicrobial treatment guidelines for acute bacterial rhinosinusitis. [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2004

6

antimicrobial treatment guidelines for acute bacterial rhinosinusitis. [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2004